Luis Enrique Pizarro Maqueda
Direttore/Membro del Consiglio presso Drugs for Neglected Diseases initiative
Profilo
Luis Enrique Pizarro Maqueda is currently the Executive Director at Drugs for Neglected Diseases initiative since 2022.
Prior to this, he worked as the Director-Internal Audit at Abengoa SA from 2005 to 2013.
He completed his undergraduate degree from the University of Seville, graduate degree from Universidad Pablo de Olavide, and MBA from Instituto de Estudios Superiores de la Empresa.
Posizioni attive di Luis Enrique Pizarro Maqueda
Società | Posizione | Inizio |
---|---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Direttore/Membro del Consiglio | 05/09/2022 |
Precedenti posizioni note di Luis Enrique Pizarro Maqueda
Società | Posizione | Fine |
---|---|---|
ABENGOA, S.A. | Comptroller/Controller/Auditor | - |
Formazione di Luis Enrique Pizarro Maqueda
University of Seville | Undergraduate Degree |
Instituto de Estudios Superiores de la Empresa | Masters Business Admin |
Universidad Pablo de Olavide | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
ABENGOA, S.A. | Industrial Services |
Aziende private | 1 |
---|---|
Drugs for Neglected Diseases initiative
Drugs for Neglected Diseases initiative BiotechnologyHealth Technology Drugs for Neglected Diseases initiative provides drug research and development services. It specializes in analyzing the causes of and in developing medicine and treatments for neglected diseases. It specializes in the study of neglected tropical diseases, such as sleeping sickness (Human African Trypanosomiasis), Leishmaniasis, Chagas, malaria, pediatric HIV, and filarial diseases. It develops a research and development portfolio that includes projects from discovery through to post-registration phases. Its focus areas encompass regional disease-specific platform development, technology transfer, and public responsibility and awareness advocacies. The organization was founded in July 2003 and is headquartered in Geneva, Switzerland. | Health Technology |
- Borsa valori
- Insiders
- Luis Enrique Pizarro Maqueda